Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID ‐19-Reference-Cited by-同舟云学术

Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID ‐19

Published:2020-12-15 Issue:3 Volume:36 Page:313-321
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J Clin Apher

Author:

Katagiri Daisuke¹^ORCID,Ishikane Masahiro²,Asai Yusuke³,Izumi Shinyu⁴,Takasaki Jin⁴,Katsuoka Hiyori⁵,Kondo Isao¹,Ide Satoshi²,Nakamura Keiji²,Nakamoto Takato²,Nomoto Hidetoshi²,Akiyama Yutaro²,Miyazato Yusuke²,Suzuki Tetsuya²,Kinoshita Noriko²,Ogawa Tatsunori⁵,Togano Tomiteru⁶,Suzuki Manabu⁴,Hashimoto Masao⁴,Sakamoto Keita⁴,Kusaba Yusaku⁴,Katsuno Takashi⁴,Fukaya Takashi⁵,Hojo Masayuki⁴,Sugiyama Masaya⁷,Mizokami Masashi⁷,Okamoto Tatsuya⁸,Kimura Akio⁹,Noiri Eisei¹⁰,Ohmagari Norio²,Hinoshita Fumihiko¹,Sugiyama Haruhito¹⁰

Affiliation:

1. Department of Nephrology National Center for Global Health and Medicine Tokyo Japan

2. Disease Control and Prevention Center National Center for Global Health and Medicine Tokyo Japan

3. Antimicrobial Resistance Clinical Reference Center, Disease Control and Prevention Center National Center for Global Health and Medicine Tokyo Japan

4. Department of Respiratory Medicine National Center for Global Health and Medicine Tokyo Japan

5. Medical Equipment Management Office National Center for Global Health and Medicine Tokyo Japan

6. Department of Hematology National Center for Global Health and Medicine Tokyo Japan

7. Genome Medical Sciences Project Research Institute, National Center for Global Health and Medicine Ichikawa Japan

8. Department of Intensive Care Medicine National Center for Global Health and Medicine Tokyo Japan

9. Department of Emergency Medicine and Critical Care National Center for Global Health and Medicine Tokyo Japan

10. National Center Biobank Network National Center for Global Health and Medicine Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jca.21861

Reference42 articles.

1. Hematological findings and complications of COVID ‐19

2. Pharmacologic treatments for coronavirus disease 2019 (COVID‐19): a review;Sanders JM;JAMA,2020

3. COVID-19: consider cytokine storm syndromes and immunosuppression

4. Effective treatment of severe COVID-19 patients with tocilizumab

5. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood perfusion with polymyxin B immobilized columns in patients with COVID-19 requiring oxygen therapy;Scientific Reports;2024-05-31

2. Antimicrobial Peptides and Their Assemblies;Future Pharmacology;2023-10-19

3. Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2;MedComm;2023-05-14

4. Outcome and Complications of Hemoperfusion in Patients with COVID-19 in Intensive Care Unit: A Cross-Sectional Study;Cardiovascular & Hematological Agents in Medicinal Chemistry;2023-03

5. Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review;Frontiers in Immunology;2023-02-03